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Galectin-1 (Gal-1) and galectin-3 (Gal-3) arewidely ex-
pressed galectins with immunoregulatory functions in
animals. To explore their glycan specificity, we devel-
opedmicroarrays of naturally occurring glycans using
a bifunctional fluorescent linker, 2-amino-N-(2-amino-
ethyl)-benzamide (AEAB), directly conjugated through
its arylamine group by reductive amination to free
glycans to form glycan-AEABs (GAEABs). Glycans
from natural sources were used to prepare over 200
GAEABs, which were purified by multidimensional
high-pressure liquid chromatography and covalently
immobilized onto N-hydroxysuccinimide-activated
glass slides via their free alkylamine. Fluorescence-
based screening demonstrated that Gal-1 recognizes
a wide variety of complex N-glycans, whereas Gal-3
primarily recognizes poly-N-acetyllactosamine-con-
tainingglycans independentofN-glycanpresentation.
GAEABs provide a general solution to glycanmicroar-
ray preparation from natural sources for defining the
specificity of glycan-binding proteins.
INTRODUCTION
Immunological homeostasis relies on effective expansion of
innate and adaptive immune leukocytes during inflammation
andcontractionof activated leukocytesduring resolutionof these
inflammatory events (Nussler et al., 1999). Failure to appropri-
ately control activated leukocytes following the response often
results in damage of viable tissue and can result in autoimmunity.
Many factors regulate leukocyte turnover, including members of
the tumor necrosis factor (TNF) and galectin families (Elola et al.,
2007; Opferman, 2008). TNF family members induce leukocyte
contraction throughapoptosis,whereasgalectin familymembers
induce leukocyte turnover and regulate leukocyte behavior
through both apoptotic and apoptosis-independent pathways,
depending on the cell type and activation state (Rabinovich
et al., 2007a; Stowell et al., 2008b; Toscano et al., 2007b).
In contrast to TNF family members, which engage trimeric
counter-receptors throughprotein-protein interactions, galectins
signal through multivalent recognition of cell surface carbohy-
drate structures (Brewer, 2001; Rabinovich et al., 2007b).
However, the carbohydrate structures through which galectins
regulate leukocyte viability remain uncertain. Recent studies,
using a combined approach of cell surface binding studies and36 Chemistry & Biology 16, 36–47, January 30, 2009 ª2009 Elseviavailable glycan microarrays, provided key insight into carbohy-
drate recognition by galectin-1 (Gal-1) and galectin-3 (Gal-3),
the two most well-studied galectins. Gal-1 and Gal-3 appear to
recognize poly-N-acetyllactosamine (3Galb1-4GlcNAcb1-)n
(polyLacNAc) cell surface glycans, although the underlying
mechanism for this preference appears to fundamentally differ
(Leppanen et al., 2005; Stowell et al., 2008a). Other studies
suggest that Gal-1 and Gal-3 prefer highly branched complex
N-glycans (Guo et al., 2008; Hirabayashi et al., 2002; Walzel
et al., 2006) and that galectin signaling is related to N-glycan
branching (Lau et al., 2007; Karmakar et al., 2008), but there is
uncertainty about the structures and roles of N-glycans in galec-
tin signaling (Carlow et al., 2003; Karmakar et al., 2008). Distinct
LacNAc modifications appear to differentially alter Gal-1 and
Gal-3binding tochemically definedandcell surfaceglycans (Car-
lowet al., 2003; Leffler andBarondes, 1986; Stowell et al., 2008a).
Although these studies provide insight into the glycan recogni-
tion patterns of Gal-1 and Gal-3, the preference of Gal-1 and
Gal-3 for LacNAc modifications in the context of N-glycans, as
occurs on cell surface glycans, remains uncertain. These uncer-
tainties are due largely to the difficulty in chemically synthesizing
complex N-glycans for inclusion on defined glycan microarrays.
Although current glycan microarrays contain unprecedented
numbers of chemically defined and structurally diverse glycans,
many structures represent only terminal glycan structures inde-
pendent of the context of their expression on glycoproteins as
N- or O-linked glycans or on glycolipids (Blixt et al., 2004).
Although some glycan binding proteins might only recognize
terminal modifications irrespective of the core glycan structure,
several studies suggest that the core structure significantly influ-
ences terminal glycan recognition (Chandrasekaran et al., 2008;
Chiu et al., 1994; Roseman and Baenziger, 2001).
A solution to the problem of presenting naturally occurring,
complex glycan structures to potential glycan-binding proteins
is to produce a ‘‘natural glycan microarray,’’ in which glycans
from natural sources are derivatized, separated, and immobi-
lized. This approach is more relevant to biological systems,
because glycans can be directly prepared from target cells or
tissues. However, for natural glycan microarrays to be practical,
strategies for simple and efficient separation and quantification
of glycans obtained from natural sources will be required.
Here we report the synthesis of a novel fluorescent linker, 2-
amino-N-(2-amino-ethyl)-benzamide (AEAB) and its conjugation
to free reducingglycansobtained fromnatural sources. The result-
ingglycan-AEABconjugates (GAEABs) retain fluorescence similar
to the glycan-2,6-diaminopyridine (DAP) conjugates reported
previously (Xia et al., 2005); however, the arylamine is replaced
with a primary alkylamine functional group for more efficienter Ltd All rights reserved
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ized surfaces. Using this approach, we constructed a glycan mi-
croarray incorporating more than 200 glycans from commercially
available glycans andglycansobtained fromnatural sources.With
this structurally diverse natural glycan microarray, we evaluated
glycan recognition by Gal-1 and Gal-3 and found substantial
differences in the types of glycans these galectins recognize.
Our studiesdemonstrate theutilityof thisnovelapproach tomicro-
array development andprovide a newmethod for the evaluationof
many other glycan binding proteins.
RESULTS
Synthesis of AEAB and Its Conjugation with Glycan
AEAB is synthesized by aminolysis of methyl anthranilate (MA)
with ethylenediamine (EDA) (Figure 1a). Because the resulting
AEAB possesses both an aromatic and an aliphatic amine, which
readily react with hemiacetals of reducing glycans by reductive
amination, two conjugates, glycan-AEAB1 and glycan-AEAB2,
could theoretically be obtained (Figure 1B). To characterize the
products of this reaction, we conjugated the pentasaccharide,
lacto-N-fucopentaose III (LNFPIII) (structure 37 in Table S1 avail-
able online), with MA by reductive amination followed by aminol-
ysis by EDA to generate only the LNFPIII-AEAB2 conjugate
(Figure 1C), which was subjected to high-pressure liquid
chromatography (HPLC) analysis (Figure 1D, top). Using well-
known reductive amination conditions, free reducing LNPFIII
(1–10 nmol) was mixed with 0.35 M AEAB (5 ml) plus 1 M sodium
cyanoborohydride (NaCNBH3, 5 ml) in dimethylsulfoxide (DMSO)/
acetic acid (AcOH) (7/3 v/v) and heated at 65C for 2h. As pre-
dicted, the conjugation of LNFPIII with AEAB generated two
conjugates, presumably LNFPIII-AEAB1 and LNFPIII-AEAB2
(Figure 1D, bottom). By comparing the HPLC profiles (Figure 1D)
of the products from the direct conjugation of LNFPIII with AEAB
and the EDA aminolysis product of LNFPIII-MA conjugate,
LNFPIII-AEAB1 and LNFPIII-AEAB2 were easily identified (Fig-
ure 1D). HPLC-purified LNFPIII-AEAB1 and LNFPIII-AEAB2
showed the same mass ([M+Na]+ 1039.326) by matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF MS) analysis (Figure 1E), which matched the calcu-
lated theoretical value ([M+Na]+ 1039.407).
Optimization of Glycan-AEAB Conjugation
Glycan-AEAB2 conjugates are desirable because they have
a primary alkylamine group, which is more reactive than aryl-
amine groups. To improve the chemoselectivity between the
arylamine and alkylamine groups on AEAB, we varied the acidity
of the reaction using the model compound LNFPIII. The ratio of
LNFPIII-AEAB1 to LNFPIII-AEAB2 was analyzed by HPLC on
a porous graphitized carbon (PGC) column (Figure 2a) as a func-
tion of varying amounts of AcOH in the reaction mixture. When
pure DMSO was used as the solvent for derivatization, the reac-
tion was very slow and impractical. As the amount of AcOH was
increased from 10% to 40%, the preferred product shifted from
LNFPIII-AEAB1 to LNFPIII-AEAB2 (Figure 2A). This indicated that
at higher acidity, reductive amination via the arylamine was
favored over the alkylamine, consistent with the aliphatic amine
being more nucleophilic and basic than the aromatic amine and
therefore more likely to be protonated (Figure 2B). After proton-Chemistry & Biology 16ation, the nucleophilicity of the aliphatic amine dramatically
decreases so that the unprotonated aromatic amine became
more reactive toward the reducing end of glycans to form
a Schiff’s base, which was reduced by NaCNBH3 to give the final
glycan-AEAB2 conjugate.
To further increase the protonation of AEAB and make a more
convenient reagent, we treated AEAB with excess hydrochloric
acid before its conjugation with glycans. The conjugation of
LNFPIII with this pre-protonated AEAB hydrochloride salt in
DMSO/AcOH (7/3 v/v) gave LNFPIII-AEAB2 as the dominant
product with only trace amounts of LNFPIII-AEAB1 (Figure 2A).
When an aliphatic amine is totally protonated, it loses its reac-
tivity toward aldehydes. The reductive amination of an aromatic
amine with reducing glycans, however, is not dramatically
affected by protonation due to its lower basicity. One concern
with the AEAB-HCl salt is that its acidity might affect sialic acid
residues on glycans. We evaluated this by comparing HPLC
profiles of LS tetrasaccharide c (LSTc)-2-aminobenzoic acid
(2AB) conjugate versus the LSTc-AEAB conjugate (Figure 2C)
and by testing the profiles of sialyllactose versus lactose by
HPLC (Figure 2D). It is known that 2AB conjugation under this
condition does not affect sialic acid residues (Bigge et al.,
1995). The similarities of the HPLC profiles of LSTc-2AB and
LSTc-AEAB, and the lack of a peak corresponding to lactose
in the sialyllactose samples indicated no significant desialylation
(%1%) during AEAB conjugation under the above reductive ami-
nation conditions.
To address the conjugation efficiency of AEAB with reducing
glycans, we compared the profiles of free reducing LNFPIII and
the crude AEAB conjugation product by high-pH anion-
exchange chromatography with pulsed amperometric detection
(HPAEC-PAD) (Figure 2E). The results show that more than 98%
of the reducing LNFPIII was converted to LNFPIII-AEAB under
the above reaction conditions. The conjugation efficiency of
AEAB with glycans was not dependent on the glycan structure.
Printing Efficiency of Different Glycan Conjugates
on Surface-Activated Glass Slides
To explore the use of AEAB for constructing glycan arrays, the
printing efficiency of LNFPIII-AEAB1 and LNFPIII-AEAB2 were
tested on NHS- and epoxy-activated glass slides. LNFPIII-
AEAB1, LNFPIII-AEAB2, and LNFPIII-DAP were printed side by
side along with free LNFPIII, DAP, and AEAB as controls. The
printing (coupling) efficiency was indirectly estimated by fluores-
cent lectin binding. Biotinylated Aleuria aurantia lectin (AAL) de-
tected with cyanine 5-streptavidin (Cy5-SA) was used to detect
immobilized LNFPIII. On NHS slides (Figure S1A), the stronger
fluorescence signal of LNFPIII-AEAB2 compared with LNFPIII-
AEAB1 supports the conclusion that LNFPIII-AEAB2 possesses
the more reactive primary alkylamine group (Figure 1b). LNFPIII-
AEAB2 can be detected at 2-fold lower printing concentration
than LNFPIII-DAP and 4-fold lower printing concentration than
LNFPIII-AEAB1, indicating an enhanced printing efficiency. On
epoxy slides, the minimum detectable printing concentrations
are lower than on NHS slides. Thus, whereas epoxy slides
provide somewhat higher sensitivity, the reaction is less specific
(Figure S1B); that is, underivatized LNFPIII, free AEAB, and DAP
show undesirable, nonspecific binding signals. Unexpectedly,
on epoxy slides, LNFPIII-AEAB2 does not show a lower, 36–47, January 30, 2009 ª2009 Elsevier Ltd All rights reserved 37
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(A) Synthesis of AEAB.
(B) Expected products of conjugation of AEAB with glycans.
(C) Conjugation of LNFPIII with MA, treated with EDA to give only LNFPIII-AEAB2.
(D) HPLC profiles of EDA treatment of LNFPIII-MA conjugate (top) and the direct conjugation of LNFPIII with AEAB under normal reductive amination condition
(bottom).
(E) MALDI-TOF MS spectra of HPLC-purified LNFPIII-AEAB1 and LNFPIII-AEAB2.minimum detectable concentration than LNFPIII-AEAB1,
although both show lower minimum detectable concentrations
than LNFPIII-DAP. It is possible that dual reactions on epoxy
through both the primary arylamine and secondary alkylamine
functional groups of LNFPIII-AEAB1 might occur, because they
are similarly reactive toward epoxy. Therefore, its printing effi-
ciency is even higher than that of LNFPIII-AEAB2, which bears
a highly reactive primary alkylamine and an inert secondary aryl-38 Chemistry & Biology 16, 36–47, January 30, 2009 ª2009 Elsevieramine. Nevertheless, the strong signals from LNFPIII-AEAB2 on
both NHS and epoxy slides show the utility of AEAB as a fluores-
cent linker for natural glycan array development. Similar to
LNFPIII-DAP, immobilized LNFPIII-AEAB2 showed weak direct
fluorescencesignalswhen thearraywasscannedusingexcitation
495 nm and emission 520 nm (data not shown), although these
wavelengths are far from the optimal excitation 330 nm and emis-
sion 420 nm. Although weaker than that of LNFPIII-DAP, theLtd All rights reserved
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and quality control of the glycan microarray while not interfering
with subsequent binding assays (Song et al., 2007; Xia et al.,
2005). With the future development of ultraviolet irradiation (UV)
lasers for microarray scanners, accurate on-slide quantification
can be expected with the AEAB linker.
We have shown previously that fluorescent glycan conjugates
prepared with arylamines using DAP can be used to construct
quantifiable glycan microarrays on epoxy slides (Song et al.,
2007). Recently it was reported that 2AB and 2AA glycan deriv-
atives can be used for printing natural glycan microarrays on
epoxy-derivatized slides (de Boer et al., 2007). The covalent
Figure 2. The Optimization of AEAB Conju-
gation Using LNFPIII
(A) HPLC profiles of AEAB conjugated with LNFPIII
at different conditions of acetic acid and with the
pre-protonated HCl salt of AEAB.
(B) Proposed mechanism of the acidity effect on
the chemoselectivity between arylamine and alkyl-
amine during the AEAB derivatization.
(C) Comparison of HPLC profiles of LSTc-2AB and
LSTc-AEAB.
(D) Comparison of HPLC profiles of 30-sialyllac-
tose, 60-sialyllactose, and lactose.
(E) HPAEC-PAD profiles of free reducing LNFPIII
and crude AEAB conjugation product.
linkage of the glycan derivatives to epoxy
is through the secondary arylamine,
formed when 2AA or 2AB are coupled to
reducing glycans via reductive amination.
Although reactivity of this secondary
amine to epoxy slides is sufficient for
preparing microarrays of derivatized
glycans, this functional group is not bound
by NHS-derivatized slides. More impor-
tantly, as shown in Figure S1C, AEAB
conjugates couple with much higher effi-
ciency than those of 2AA and 2AB when
printed on either NHS or epoxy slides.
Based on the high efficiency of printing,
the low background binding, and the flex-
ibility of AEABderivatives on different acti-
vated surfaces, we used glycan-AEAB
conjugates for preparing natural glycan
arrays.
Construction of a 52-GAEAB
Microarray from Free Reducing
Glycans
To demonstrate the utility of the AEAB
linker, we prepared GAEABs from 52
commercially available, free reducing
glycans, which are shown as symbols in
Table S1. The GAEAB derivatives from 1
to 10 nmol of each pure glycan were puri-
fied using HPLC by following their fluo-
rescence and UV absorption. Each
GAEAB was quantified and adjusted to
a final concentration of 100mM for printing. Together with four
controls (AEAB, underivatized LNFPIII, buffer, and biotin-hydra-
zine), the 52 GAEABswere printed in replicates of 6 onNHS-acti-
vated slides. A total of 14 replicated subarrays containing 56
samples were printed on each slide. The printing format for con-
structing this GAEAB microarray is shown in Figure S2. Some
duplicate structures do occur on the array, decreasing the total
number of unique glycans, but the duplicate structures serve
as an internal control.
After printing, slides were incubated and blocked as described
in Experimental Procedures. A single rehydrated slide was fitted
with a silicon grid separating the slide into 14 chambers, isolating
Chemistry & Biology 16, 36–47, January 30, 2009 ª2009 Elsevier Ltd All rights reserved 39
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Fluorescent Natural Glycan Microarrayseach subarray. Each subarray can be interrogated individually
with various biotinylated lectins that are subsequently detected
by Cy5-SA. For each lectin analyzed, a histogram representing
average relative fluorescence units (RFU) bound to each glycan
is shown in Figure 3. The fluorescent image for the correspond-
ing lectin is shown as an insert in its histogram. All histograms in
Figure 3 showed expected binding specificity with an excellent
signal/noise ratio and high precision of measurement (%CV <
10%). For example,Ricinus communis agglutinin I (RCA-I) bound
well to glycans having terminal nonreducing b1,4-linked Gal resi-
dues, known to be high-affinity ligands for RCA-I (Cummings,
1994; Merkle and Cummings, 1987; Yamamoto et al., 1998).
However, it does not bind to lactose-AEAB, possibly because
of the open-ring structure of the neighboring glucose unit.
Each of the other lectins showed similar predicted specificity,
such as concanavalin A (Con A) recognition ofmannose-contain-
ing glycans, AAL binding to fucosylated glycans, Sambucus
nigra agglutinin (SNA) and Maackia amurensis agglutinin (MAA)
binding to sialylated glycans, and Psophocarpus tetragonolobus
lectin (PTL) binding to blood group A (Pueppke, 1979). These
results demonstrate the robust utility of the preparation and
printing of GAEABs prepared from large, complex glycans that
would be impractical to synthesize chemically. The validity of
the array is confirmed by the specificity of the lectins detecting
GAEABs printed on the NHS-derivatized slides. Although most
lectin binding was specific for the expected glycan, AAL, for
example, bound several nonfucosylated glycans. This binding
is likely due to the high concentration of lectin used, which can
highlight binding to weakly recognized glycans on the microar-
ray. In the subarray analyses, AEAB linker alone (#53), buffer
(#55), and the underivatized LNFPIII (#54) showed no binding,
whereas the biotin-hydrazide (#56), was detected on all subar-
rays by Cy5-SA (Figure 3).
N-Glycan Release, Conjugation, and 2D-HPLC
Separation
Several commercially available glycoproteins, including chicken
ovalbumin, bovine fetuin, bovine immunoglobin G (IgG), and
porcine thyroglobulin, were selected for expansion of the natural
glycan microarray. The overall workflow for generating ‘‘natural
glycans’’ from natural products is shown in Figure 4. N-glycans
were released from denatured glycoproteins as described in
Experimental Procedures. The free reducing N-glycans were
conjugated with AEAB, and the fluorescent-labeled glycan
mixture was separated by 2-dimensional (2D) HPLC. GAEABs
were readily separated using a combination of chromatographic
methods including an amide or normal phase (NP) column, a C18
reverse phase (RP) column, or a PGC column. These orthogonalmethods are useful for multi-dimensional-HPLC purification of
GAEABs. For all three columns, acetonitrile and water were
used as the solvents. With the NP column, ammonium acetate
salt was used as the modifier whereas 0.1% TFA was used as
themodifier for both RP and PGCcolumns. TheNP or RP column
was chosen for the first-dimension HPLC separation, and the
PGC column was always chosen for the second-dimension
separation because of its excellent resolution and desalting
effect. A typical 2D-HPLC separation for N-glycans released
from ovalbumin is shown in Figure 5. In Figure 5A, 20 fractions
from NP HPLC were collected, and each fraction was further
fractionated by the PGC column (Figure 5B). Fractions appearing
to contain near-homogeneous GAEABs were collected, and the
collected samples were dried, reconstituted, and repurified
using a short PGC cartridge, which allowed for purification to
homogeneity and quantification. Each fraction containing
a defined amount of GAEAB derivative was dried and dissolved
in printing buffer to a final concentration of 100 mM. These solu-
tions were used to print each glycan in triplicate on the NHS-acti-
vated glass slides, generating a natural N-glycan microarray.
Glycan released from other glycoproteins, such as bovine fetuin,
IgG, and thyroglobulin, were derivatized and processed for
printing using the same method. By incorporating all fractions
and 84 GAEABs individually prepared from commercially avail-
able oligosaccharides and defined free glycans, we constructed
a glycanmicroarray withmore than 200 glycanswithin each of 14
subarrays on a single slide. Table S2 provides a description of
the glycans printed on this array. We have noted the presence
of N-glycans with only 1 GlcNAc instead of R2, presumably
due to the known contamination of some commercial PNGaseF
with endo-beta-N-acetylglucosaminidase F activity. The defined
glycans are shown in symbols and the natural glycans are repre-
sented by their compositional analysis determined by MALDI-
TOF MS.
Nomenclature and Compiling of GAEAB Fractions
Due to the rapid production of large numbers of GAEABs using
this natural glycan array technology and the fact that detailed
sequence analysis is not necessary if the glycan is not detected
by a glycan binding protein, we simply identified the fractions
systematically for easy data collection and analysis. Naming iso-
latedGAEAB fractionswasbasedon theHPLCseparationproce-
dure. For example, bovine IgG-AEAB-NP03-PGC02 represents
four columns of information, which designate the source (bovine
IgG), derivatization method (AEAB), first dimension of NP HPLC
fraction number (NP03), and second dimension of PGC HPLC
fractionnumber (PGC02), respectively.Morecolumnsof informa-
tion can be added, such as additional separation steps and theFigure 3. Lectin-Binding Assay on a 52 GAEAB Microarray
Subarrays were separated by incubation chambers and incubated with various biotinylated lectins followed by Cy5-SA. The Cy5 fluorescence image is scanned
and shown as the red, 10 mm 3 10 mm insert. The error bars represent the standard deviation of six replicates.
(A) RCA I binds to terminal Galb1,4-GlcNAc.
(B) Con A binds to all N-glycans but not triantennary and tetra-antennary complex type N-glycans.
(C) AAL binds to all fucose-containing glycans.
(D) SNA binds to terminal a2,6-sialic acid.
(E) MAA binds to Neu5Aca2-3Galb1,4-.
(F) PTL binds to blood group A tetrasaccharide and pentasaccharide. Biotin spots printed on each subarray serve as an alignment feature to localize each
subarray on the slide.
Chemistry & Biology 16, 36–47, January 30, 2009 ª2009 Elsevier Ltd All rights reserved 41
Chemistry & Biology
Fluorescent Natural Glycan MicroarraysFigure 4. The General Strategy of Natural Glycan Array Development Using Complex Glycoconjugates as Starting Materialsmass of the glycan. Thus, a glycan mapping system can be
devised based on HPLC retention time and MS data as a large
library is constructed. A clear, easily expandable, and searchable
database for the GAEAB fractions is essential for computer-
assisted high-throughput analysis, especially because the
potentially unlimited GAEAB library will rapidly expand.
MALDI-TOF MS of GAEAB Fractions
All GAEAB fractions were characterized by MS. Figure S3 shows
examples of the MS and MS/MS spectra of two fractions from
bovine IgG, neutral bovine IgG-AEAB-NP05-PGC01, and sialy-
lated bovine IgG-AEAB-NP14-PGC02. All neutral GAEABs
gave clean MS spectra and informative MS/MS data. Composi-
tion and tentative structures of neutral glycans can be assigned
according to the MS data and published information on glycans
from various sources. The fragmentation pattern in Figure S3A
shows losses of a deoxyhexose (146) and a HexNAc (203),
respectively, suggesting a fucosylated biantennary structure
with one branch degalactosylated. Figure S3B shows the MS
and MS/MS spectra of a monosialylated glycan. It is clear that
in positive mode, desialylation fragmentation is observed. The
fragmentation pattern of the desialylated parent ion at 1810.6
is almost identical to that of Figure S3A, indicating the same skel-
etal structure. In negative mode analyses, however, a single
peak is observed, confirming the existence of a terminal Neu5Gc
(±307). Combining the information from MS and MS/MS spectra
in different modes, the composition and structure of acidic
sugars can also be proposed.
Binding of Gal-1 and Gal-3 on the Natural Glycan
Microarray
The availability of this large glycan array (>200 glycans)
composedofmanyhigh-molecular-weight, complex,multianten-42 Chemistry & Biology 16, 36–47, January 30, 2009 ª2009 Elseviernary N-glycans allowed us to explore the glycan binding speci-
ficity of human Gal-1 and Gal-3 (Camby et al., 2006; Dumic
et al., 2006; Ohtsubo et al., 2005; Stowell et al., 2007) in greater
depth. These galectins are thought to recognize polyLacNAc
sequences inN-and/orO-glycans (Leppanenet al., 2005;Stowell
et al., 2008a), but existing microarrays have few large, complex
N-glycans to allow testing of the galectin binding specificity
(http://www.functionalglycomics.org/).
Gal-1 and Gal-3 exhibited somewhat similar binding patterns
when evaluated at relatively high concentrations (6–7 mM)
(Figures 6A and 6B). At these concentrations their glycan spec-
ificity was similar to that reported with Gal-1 exhibiting higher
binding toward N-glycans and Gal-3 recognizing blood group
antigens, thus generally validating this overall natural glycan mi-
croarray relative to available microarrays (Stowell et al., 2008a).
Furthermore, a2-6 sialylation blocked Gal-1 and Gal-3 recogni-
tion, whereas a2-3 sialylation had no effect on binding, consis-
tent with prior findings (Stowell et al., 2008a). However, because
many ligands were bound at near-saturating levels (40,000–
50,000 RFU) using this high concentration of galectins, we eval-
uated the binding at lower concentrations (1.5 mM and lower,
Figures 6C–6F), which reflect physiological lectin levels. We
found previously that both Gal-1 and Gal-3 recognize cell
surface glycans at submicromolar levels (Leppanen et al.,
2005; Stowell et al., 2008a). At less than 1 mM, Gal-1 and Gal-3
exhibited striking differences in their glycan recognition. Gal-1
displayed significant binding toward many N-glycans, including
glycans 001, 011, 025, and 094 (Figure 6E and Table S3). All of
these glycans are characterized by biantennary presentation of
terminal b4-linked galactose. By contrast, Gal-3 at this concen-
tration did not bind those N-glycans, but rather recognized
glycans containing a repeating unit of Gal-GlcNAc (LacNAc),
as found in glycans 016, 026, and 078 (Figure 6F and TableLtd All rights reserved
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ages, rather than Galb1-4 linkages, as found in glycan 016. The
ability of Gal-3 to bind glycans such as 026 and 078 is novel to
our study, because such glycans are not presently available on
the glycan microarray from the Consortium for Functional Glyco-
mics (CFG). Previous studies have showed that short (Galb1-
3GlcNAc or Galb1-3GlcNAcb1-3Galb1-3GlcNAc) type 1 glycans
are not bound by Gal-3 (Stowell et al., 2008a). These results
demonstrate that although Gal-1 and Gal-3 exhibit high affinity
for some N-glycans, each possesses distinct differences in
N-glycan recognition, providing the first significant differences
in the recognition of naturally occurring glycans by these two lec-
tins. Gal-3 significantly preferred glycans containing LacNAc
repeating units, as found in polyLacNAc cell surface glycans.
DISCUSSION
The strategy we have employed for natural glycan microarray
development is shown in Figure 4. A complex mixture of glycans
derived from naturally occurring glycoconjugates by chemical
or enzymatic procedures is derivatized with a bifunctional fluo-
rescent linker AEAB using a quantitative and glycan-specific
method. The fluorescent glycan mixture is separated into
individual components by chromatographic methods and indi-
vidually characterized by MS and other methods to define their
structures. The purified glycans are immobilized onto a solid
Figure 5. 2D-HPLC Separation of Fluorescent-Labeled Glycans
Released from Ovalbumin
(A) First-dimension HPLC separation using NP column.
(B) Second-dimension HPLC separation of glycans collected from (A) using
PGC column.Chemistry & Biology 16phase through their primary alkylamine, directly or after being
activated to another suitable functional group.
Glycanmicroarrays have been produced from naturally occur-
ring glycans using nonfluorescent linkers for coupling glycans to
solid surfaces (Feizi and Chai, 2004; Feizi et al., 2003). Fluores-
cent linkers provide two important advantages for developing
microarrays. First, the fluorescent tags produced by glycan-
specific reductive amination incorporates 1 mol label per mol
glycan to provide a detection method for monitoring the purifica-
tion and for quantifying individual glycans, which are otherwise
not detected by simple, nondestructive spectrophotometric
methods. Second, the fluorescent tag permits the application
of this approach to glycans derived from cell and tissue glyco-
conjugates, which are generally available in only limited quanti-
ties. For example, preparation of glycan microarrays using fluo-
rescent-tagged glycans requires only 1 to 2 nmol of each
fluorescent glycan (10–20 ml of a 100 mM solution); because
noncontact printing can deliver 333 pl at 5% intertip variation,
this amount of material could print thousands of microarrays
with each glycan printed in triplicate.
We have shown that free reducing glycans can be readily
derivatized with the novel fluorescent linker AEAB to generate
GAEAB derivatives that are efficiently derivatized to either
NHS- or epoxy-activated glass slides. Although both amino
groups of AEAB can potentially react with the reducing glycan
by reductive amination to give two isomers, we successfully
differentiated the two amino groups by using the AEAB-HCl
salt for glycan derivatization. The simple AEAB derivatization is
a mild reaction analogous to other commonly used fluorescent
labels (2AB and DAP). GAEAB derivatives, shown here to be
superior to previously described fluorescent linkers, provide
a new direction for generating large libraries of naturally occur-
ring glycans from cell and tissue glycoconjugates because this
derivatization does not affect relatively labile sialic acid and
sulfate residues on glycans. The derivatives have excellent sepa-
ration characteristics on HPLC as shown in Figure 5; unlike many
fluorescent derivatives, they are amenable to MS analysis
directly by MALDI/TOF or by spectrometric analysis of perme-
thylated derivatives (data not shown), and coupling via the alkyl-
amine to NHS-derivatized glass slides is quite efficient in
preparing microarrays.
Our previous study showed that DAP derivatization of glycans
(Song et al., 2007; Xia et al., 2005) is an appropriate method for
natural glycan array development, especially on epoxy-activated
slides. However, the relatively low reactivity of the arylamine
derivative of the glycans toward various leaving groups
compared with the aliphatic amine derivative AEAB limited this
approach to epoxy-derivatized slides, where the highly reactive
epoxy groups react with both primary and secondary amines,
and in some cases might react with hydroxyl groups, causing
a heterogeneous presentation of glycans on an array. Epoxy-
derivatized slides also generated much higher backgrounds
with complex samples due to nonspecific binding of fluorescent
detecting reagents, thusmaking them less desirable when highly
sensitive detection is required. For these reasons, common fluo-
rescent derivatives such as 2AA and 2AB, which can only be
printed on epoxy slides (de Boer et al., 2007), are not as desirable
as AEAB and other bifunctional fluorescent linkers having an
alkylamine available for coupling to derivatized surfaces., 36–47, January 30, 2009 ª2009 Elsevier Ltd All rights reserved 43
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(A) Gal-1 at 7 mM. The natural sources of the GAEABs are marked with different colors. Glycan 016 is a mixture of isomers with an 80/20 ratio. The error bars
represent the standard deviation of three replicates.
(B) Gal-3 at 6 mM.
(C) Gal-1 at 0.44 mM.
(D) Gal-3 at 1.5 mM.
(E) Gal-1 at 0.11 mM.
(F) Gal-3 at 0.7 mM.Using this novel fluorescent derivatizationmethod, we derivat-
ized many commercially available, free reducing glycans (Table
S1) using only 1–10 nmol (1–50 mg) of glycan. Thus, natural
glycan sources can be employed as an almost unlimited library
of glycan structures. By contrast, most glycans included in
printed glycan microarrays, such as those of the CFG, are chem-44 Chemistry & Biology 16, 36–47, January 30, 2009 ª2009 Elsevieically or enzymatically synthesized (Blixt et al., 2004), and typi-
cally milligrams of each glycan are required for maintaining
a nonfluorescent glycan library. For this reason, nontagged
glycan libraries and their corresponding microarrays will expand
slowly, because of the high cost and difficulty of chemical
synthesis. With the technique described here, more than 200r Ltd All rights reserved
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commercially available glycoproteins in a rapid and parallel
fashion. More importantly, the GAEAB library can be easily
expanded, using unlimited glycan sources from nature. In this
GAEAB library, 35 GAEABs were prepared from complex
N-glycan structures that are not available on the CFG glycan
array, because of their difficult synthesis. Many sialylated and
sulfated glycans were also included to represent the structural
diversity,whichproved thegeneral applicability of this fluorescent
derivatizationmethod on different glycan structures. Recently, an
N,O-dialkylamine was developed as a new bifunctional linker for
glycan derivatization (Bohorov et al., 2006). Although this
approach can retain the ring-closed structure of free reducing
glycans, the glycan cannot be detected by common sensitive
spectrophotometric or fluorometric methods. Therefore, it is
useful only for pure compounds that are available in large quanti-
ties. The AEAB fluorescent derivatization successfully circum-
vents these problems without diminishing printing efficiency.
AlthoughAEABderivativespossessa reduced terminalmonosac-
charide, most carbohydrate recognition by glycan binding
proteins involves recognition of the nonreducing end of glycans.
In natural glycan array development, a mixture of many
glycans from natural sources can be derivatized and separated.
To confirm that the AEAB fluorescent derivatization of glycans is
nonselective and nearly quantitative, we compared the fluores-
cent labeling of glycans with different labels. The high similarity
of the HPLC profiles of fetuin-derived glycans conjugated with
2AB, DAP, and AEAB demonstrated that derivatization by
AEAB is nonselective toward different glycans. Using appro-
priate solvent systems, the GAEAB mixtures can be separated
using various HPLC columns, such as amine NP column, C18
RP column, and PGC column. These HPLC columns have very
different retention mechanisms, thus providing the orthogonal
methods required for multidimensional chromatography. By
choosing appropriate HPLC columns, complex glycan mixtures
from human milk or mixtures released from glycoproteins, cells,
or tissues can be conjugatedwith AEAB and quickly separated in
one or more dimensions. The purified fractions can be quanti-
fied, characterized, and printed on surface-activated glass
slides. We released, labeled, and separated a large number
(>125) of N-glycans using this strategy by starting from several
commercially available, naturally occurring glycoproteins. These
homogeneous fractions were characterized with MALDI-TOF
MS and various lectins. Combined with the GAEABs prepared
directly from purified, commercially available glycans, we
constructed a glycan microarray incorporating more than 200
glycans, most of which are complex N-glycans not available on
the CFG glycan array. Although the fully defined CFG glycan
array is most useful for screening glycan-binding proteins for
binding motifs to determine specificities and relative affinities
of glycans for glycan-binding proteins, natural glycan arrays of
cells and tissues composed of partially defined glycans that
bind biologically relevant macromolecules will be useful for con-
firming the definition of a natural ligand and will permit discovery
of new protein-carbohydrate interactions. Although many
glycans separated by multidimensional HPLCmight have similar
carbohydrate compositions, their separation indicates that they
are structurally different. In addition, it is possible that even
a single peakof isolated glycanmight have aunique composition,Chemistry & Biology 1but be composed of structural isomers that copurified. Future
studies on such glycans will include additional HPLC-MS/MS
mapping systems, 3D-HPLC purification of nonhomogeneous
fractions, and more structural characterizations of glycans.
Although previous studies suggest a general preference of ga-
lectin family members for polyLacNAc glycans (Leppanen et al.,
2005; Stowell et al., 2008a), in the present study Gal-1 and Gal-3
displayed differential binding at submicromolar concentrations
of protein toward complex N-glycan and polyLacNAc-containing
glycans. Gal-1 exhibited relatively similar affinity toward many
different complex N-glycans, especially those expressing R2
terminal, nonreducing b4-linked galactose residues. The specific
binding of galectin-1 to N-glycans is consistent with recent find-
ings (Karmakar et al., 2008) that cell binding and signaling are
dependent on the expression of complex-type N-glycans. By
contrast, Gal-3 only recognized glycans containing a polyLac-
NAc extension. This preference provides the first biochemical
basis for several studies suggesting that N-glycans and polyLac-
NAc elongation differentially contribute to galectin signaling, as
has been observed in studies on T cell activation and GLUT-2
cell surface half-life through galectin-ligand interactions (Breuilh
et al., 2007; Lagana et al., 2006; Lajoie et al., 2007; Ohtsubo
et al., 2005; Wilker et al., 2007) and implicate Gal-3, along with
Gal-1 and Gal-9, as key regulators in these processes. Further-
more, the differential glycan recognition displayed by Gal-1
andGal-3 toward distinct N-glycansmight underscore the differ-
ential sensitivity of T cells and other cell types to Gal-1 and Gal-3
(Camby et al., 2006; Cao et al., 2002; Frigeri et al., 1993; La et al.,
2003; Rubinstein et al., 2004; Toscano et al., 2007a). Importantly,
there are many N-glycans on human leukocytes, especially
neutrophils, that are complex highly branched chains expressing
polyLacNAc (Babu et al., 2008). The specific, high-affinity
interactions of Gal-1 and Gal-3 for these biologically relevant
N-glycans would not have been recognized without the develop-
ment of the natural glycan array. The dose-dependent method
utilized on the array is important when both high- and low-affinity
ligands are present, helping to identify the high-affinity ligands,
which are defined as those ligands that continue to be bound
by lectin at very low lectin concentrations. Additionally, inter-
esting observations were made regarding the fine specificity of
galectin binding. Small structural differences in glycans, for
example the core fucosylation of glycan 051, dramatically
decreased the binding to Gal-1. Future studies using the type
of natural glycan microarray described here will permit compar-
ison between galectin family members for specific glycan recog-
nition. In addition, such natural glycan microarrays will be useful
for screening many types of glycan binding proteins from other
sources, such as viruses, bacteria, and serum proteins.
SIGNIFICANCE
Recognition of complex carbohydrates by glycan binding
proteins is the primary manner by which the glycome is in-
terpreted to provide information on biological processes.
However, modern glycomic research shows that each cell
and tissue of every organism generates a wide variety of
glycans and each cell type has a distinctive repertoire of
glycan structures. In addition, hundreds of glycan binding
proteins have been identified and many more are predicted6, 36–47, January 30, 2009 ª2009 Elsevier Ltd All rights reserved 45
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Fluorescent Natural Glycan Microarraysto occur. To define the interactions between these large
groups of interacting molecules, new chemical approaches
are needed. The most successful strategy to date has been
glycan microarrays using chemically synthesized glycans.
However, chemical synthesis alone only provides libraries
of known structures that are amenable to the current
synthetic mechanisms. Practical libraries of large, complex
glycans and from novel naturally occurring glycans will only
be available through the development of glycan microarrays
from naturally occurring glycans. Here we have described
a fluorescent linker strategy for rapidly, quantitatively, and
inexpensively derivatizing glycans to solid surfaces such as
glass slides. This new approach permits the preparation of
glycan microarrays that are amenable to the use of naturally
occurring glycans frombiological sources.Molecular recog-
nition of glycans by glycan binding proteins, as found in
soluble forms and in cell membranes of all organisms, will
be more readily explored using natural glycan microarrays
generated by this approach.
EXPERIMENTAL PROCEDURES
Free reducing sugars (stored at 20C) were purchased from V-labs, Inc. and
Glycoseparations (http://www.glycoseparations.com). All chemicals were
purchased from Sigma-Aldrich and used without further purification. HPLC
solvents were purchased from Fisher Scientific. PNGase F was purchased
from New England Biolabs. An Ultraflex-II MALDI-TOF/TOF system from
Bruker Daltonics was used for MALDI-TOF MS analysis of glycan conjugates.
Plant lectins were purchased from EY Labs and used at 10 mg/ml for each
lectin. Printing of glycan arrayswas performed using a Piezorray Printer (Perkin
Elmer) and analysis of glycan arrays was accomplished by scanning with a
ProScanArray Scanner (Perkin Elmer) equipped with 4 lasers.
Synthesis of AEAB
AEAB was synthesized by reacting MA with EDA, as described in the Supple-
mental Data.
Conjugation of Free Reducing Oligosaccharides with DAP, AEAB,
and MA
The fluorescent conjugation of glycans with DAP, AEAB hydrochloride salt,
and MA followed an established procedure (Xia et al., 2005) with slight modi-
fication (described in Supplemental Data).
Release of Glycans from Glycoproteins by PNGase F Digestion
PNGase F digestion was done according to the manufacturer’s instructions.
Denaturing buffer, NP40, and G7 buffer were supplied by the manufacturer.
HPLC
HPAEC-PAD analysis was performedwith aDionex ICS-3000 systemon aCar-
bopac PA-100 column. The elution gradient was set to 2.5–125 mM sodium
acetate in 100 mM sodium hydroxide over 50 min. HPLC analysis and separa-
tion of GAEABs was done on a Shimazu HPLC CBM-20A system coupled to
a UV detector SPD-20A and a fluorescence detector RF-10Axl. UV absorption
at 330 nm or fluorescence at 330 nm excitation and 420 nm emission was used
to detected glycan conjugates with DAP, 2AB, and AEAB in HPLC analysis and
separation. Both UV absorption and fluorescence intensity were used for the
quantification of GAEABs using LNFPIII-AEAB as a standard. More details
are described in Supplemental Data.
Generation of Recombinant Human Gal-1 and Gal-3
Human galectins were prepared as outlined previously (Stowell et al., 2004).
The affinity purification and biotinylation are described in Supplemental Data.46 Chemistry & Biology 16, 36–47, January 30, 2009 ª2009 ElseviePrinting, Binding Assay, and Scanning
NHS-activated slides were purchased from Schott. Epoxy slides were
purchased fromCorning. Noncontact printingwasperformedusing aPiezorray
Printer (Perkin Elmer). Biotinylated lectins were used in the binding assay and
the bound lectins were detected by a secondary incubation with Cy5-SA. The
slides were scanned with a Perkin Elmer ProScanArray microarray scanner
equipped with 4 lasers covering an excitation range from 488 to 637 nm.
The scanned images were analyzed with the ScanArray Express software.
All images obtained from the scanner are in grayscale and colored for easy
discrimination.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, three
tables, and three figures and can be found with this article online at http://
www.cell.com/chemistry-biology/supplemental/S1074-5521(08)00450-X.
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